High-concentration triple-agonist peptide for advanced metabolic research protocols.
$3,899.00 MXN
CANADA
THIRD-PARTY TESTED
Lyophilized for stability
Regarding skin health and hormonal rhythms, Retatrutide helps mitigate oxidative damage by boosting endogenous antioxidant systems (such as glutathione and catalase) and maintaining mitochondrial DNA integrity. This results in a smoother, more radiant appearance and reduced systemic inflammation—factors often linked to hormonal imbalances during perimenopause. Overall, the peptide acts as a metabolic "reset," offering women an effective tool to break through metabolic stasis, improve body composition, and promote active, healthy aging.It simultaneously activates GLP-1, GIP, and glucagon receptors.
Studied for its effects on the regulation of hunger and energy expenditure.
Greater focus for extensive and complex research designs.
Retatrutide belongs to a new class of triple-agonist peptides currently being explored in metabolic research. Various studies have examined its role in weight regulation, insulin signaling, and systemic energy balance.
Initial findings suggest that combining GLP-1, GIP, and glucagon receptor activity may yield broader metabolic effects than single-pathway compounds. This includes potential impacts on caloric intake, fat metabolism, and overall metabolic efficiency.
As research evolves, Retatrutide continues to represent a shift toward multi-pathway metabolic research—an approach particularly relevant when studying complex systems such as female metabolism.
FemmeBioLabs prioritizes data-backed compounds and transparent positioning. No assumptions, no exaggerated claims.
This site contains research compounds intended for adults
19 and older. Please confirm your age to continue.